DFTX
NASDAQ · Pharmaceuticals
Definium Therapeutics Inc
$37.65
-2.67 (-6.62%)
Open$40.03
Previous Close$40.32
Day High$40.04
Day Low$37.17
52W High$49.70
52W Low$8.77
Volume—
Avg Volume2.42M
Market Cap5.09B
P/E Ratio—
EPS$-3.43
SectorPharmaceuticals
Analyst Ratings
Strong Buy
24 analysts
Price Target
+22.2% upside
Current
$37.65
$37.65
Target
$46.00
$46.00
$39.37
$46.00 avg
$57.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 685.27M | 628.04M | 535.94M |
| Net Income | 136.42M | 119.21M | 84.03M |
| Profit Margin | 19.9% | 19.0% | 15.7% |
| EBITDA | 222.00M | 198.31M | 161.40M |
| Free Cash Flow | 100.39M | 95.21M | 82.42M |
| Rev Growth | -7.8% | +7.1% | -9.9% |
| Debt/Equity | 0.71 | 0.57 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,189.46 | +3.34% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $271.59 | +0.90% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.83 | +0.51% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.45 | +0.96% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $70.27 | -1.87% | 11.5 | 30.15B |